Clinical Drug Experience Knowledgebase

cyclophosphamide (cytoxan) (1 trial)

docetaxel (taxotere) (1 trial)

doxorubicin (Doxil) (1 trial)

paclitaxel (taxol) (2 trials)

99m-tc-hynic annexin v (1 trial)

abiraterone (zytiga) (1 trial)

amivantamab-vmjw (Rybrevant) (1 trial)

apalutamide (erleada) (1 trial)

azithromycin (zithromax) (1 trial)

capecitabine (xeloda) (1 trial)

carboplatin (paraplatin) (2 trials)

darolutamide (Nubeqa) (1 trial)

desvenlafaxine (pristiq) (1 trial)

durvalumab (imfinzi) (2 trials)

escitalopram (lexapro) (1 trial)

fluoxetine (prozac) (1 trial)

gemcitabine (gemzar) (1 trial)

hyaluronidase (human recombinant) (Hylenex) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

lapatinib (tykerb) (1 trial)

lazertinib (1 trial)

letrozole (femara) (1 trial)

octreotide (sandostatin) (1 trial)

olaparib (lynparza) (1 trial)

palbociclib (ibrance) (1 trial)

paroxetine (paxil) (1 trial)

pembrolizumab (keytruda) (2 trials)

pemetrexed (alimta) (1 trial)

pertuzumab (perjeta) (1 trial)

prednisone (meticorten) (1 trial)

sertraline (zoloft) (1 trial)

testosterone (delatestryl) (1 trial)

trastuzumab (herceptin) (1 trial)

venlafaxine (effexor) (1 trial)

vinorelbine (navelbine) (1 trial)

fludeoxyglucose f-18 (1 trial)